Who
Richard A. Meier
Director
Company insider
Files Form 4 as: Director, Accuray; Director, BioMarin Pharmaceutical; President & CFO, Rockley Photonics Holdings; EVP & Chief Financial Officer, Intersect ENT; EVP, Chief Financial Officer, Accendra Health; Director, STAAR Surgical; Exec. Vice Pres. and CFO, Teleflex; President and COO, Abbott Medical Optics.
In numbers
- Trades disclosed
- 201
- Buys
- 20
- Sells
- 11
- Bought
- $1.3M
- Sold
- $2.9M
- Companies
- 8
- Companies where not an officer
- 3
- First trade
- 24 May 2006
- Last trade
- 5 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 7 Oct 2026 | ARAY Accurayoption or derivative · Medical Devices | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 5 Oct 2026filed 7 Oct 2026 | ARAY Accurayoption or derivative · Medical Devices | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 30 Dec 2025filed 13 Feb 2026 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code G | —500 at $0.00 | filing |
| 20 May 2025filed 22 May 2025 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code A | —6,650 at $0.00 | filing |
| 3 Jun 2024filed 4 Jun 2024 | BMRN BioMarin Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code M | —6,600 at $0.00 | filing |
| 3 Jun 2024filed 4 Jun 2024 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code M | $416K6,600 at $63.10 | filing |
| 3 Jun 2024filed 4 Jun 2024 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code F | $417K5,451 at $76.41 | filing |
| 21 May 2024filed 23 May 2024 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code A | —7,080 at $0.00 | filing |
| 8 Jan 2024filed 23 Jan 2024 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code G | —3,000 at $0.00 | filing |
| 23 May 2023filed 24 May 2023 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code A | —4,190 at $0.00 | filing |
| 12 May 2023filed 17 May 2023 | BMRN BioMarin Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code M | —8,500 at $0.00 | filing |
| 12 May 2023filed 17 May 2023 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code M | $576K8,500 at $67.81 | filing |
| 12 May 2023filed 17 May 2023 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code F | $576K6,137 at $93.93 | filing |
| 21 Oct 2022filed 21 Oct 2022 | Rockley Photonics Holdingsoption or derivative | SEC FORM 4 Code A | —1,891,521 at $0.00 | filing |
| 21 Oct 2022filed 21 Oct 2022 | Rockley Photonics Holdingsoption or derivative | SEC FORM 4 Code A | —1,891,521 at $0.00 | filing |
| 24 May 2022filed 26 May 2022 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code A | —4,980 at $0.00 | filing |
| 13 May 2022filed 16 May 2022 | Intersect ENToption or derivative | SEC FORM 4 Code U | $961K34,000 at $28.25 | filing |
| 13 May 2022filed 16 May 2022 | Intersect ENToption or derivative | SEC FORM 4 Code U | $2.1M74,852 at $28.25 | filing |
| 13 May 2022filed 16 May 2022 | Intersect ENT | SEC FORM 4 Code U | $1.6M57,230 at $28.25 | filing |
| 13 May 2022filed 16 May 2022 | Intersect ENT | SEC FORM 4 Code U | $1.9M65,759 at $28.25 | filing |
News
Critical Survey: XTL Biopharmaceuticals (NASDAQ:XTLB) & BioMarin Pharmaceutical (NASDAQ:BMRN)BMRN · tickerreport.com · 18 Oct 2026BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Rating Upgraded by UBS GroupBMRN · tickerreport.com · 17 Oct 2026Contrasting Teleflex (NYSE:TFX) & Trinity Biotech (NASDAQ:TRIB)TFX · tickerreport.com · 16 Oct 2026BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price Expected to Rise, Barclays Analyst SaysBMRN · themarketsdaily.com · 14 Oct 2026Wall Street Zen Upgrades STAAR Surgical (NASDAQ:STAA) to BuySTAA · themarketsdaily.com · 12 Oct 2026
0 headlines in the last 90 days name Richard A. Meier; 5 articles from the last 14 days about the 4 companies they traded most, at most three about any one of them.